Zeitschrift für Rheumatologie

The most recent articles from: Z Rheumatol May 2018

Z Rheumatol · May 2018

Meta Analysis

Comparative efficacy and safety of baricitinib 2 mg and 4 mg in patients with active rheumatoid arthritis : A Bayesian network meta-analysis of randomized controlled trials.

This study aimed to assess the relative efficacy and safety of once-daily baricitinib 2 mg and 4 mg administration in patients with active rheumatoid arthritis (RA). ⋯ Baricitinib 2 mg and 4 mg administered once daily, in combination with DMARD, were efficacious interventions for active RA that had no significant risk of TEAE development.

read more… or just mark as read…

What will the 'Medical Journal of You' look like?

Start your free 21 day trial now.